Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.51 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | GSK3A | P49840 | 1/20 | 0.43 |
| ▸ | GSK3B | P49841 | 1/20 | 0.43 |
| ▸ | SOD1 | P00441 | 1/20 | 0.43 |
| ▸ | HMOX1 | P09601 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9849395 | 0.96 | CYP19A1 (0.52) | CYP19A1TBXAS1POLBTSHRGAA | |
| SCHEMBL9849700 | 0.84 | CYP19A1 (0.51) | CYP19A1TBXAS1POLBTSHRGAA | |
| SCHEMBL9849690 | 0.80 | POLB (0.44) | CYP19A1TBXAS1POLBTSHRALDH1A1 | |
| SCHEMBL9849636 | 0.78 | TSHR (0.54) | TSHRGAAALDH1A1GSK3AGSK3B | |
| SCHEMBL11247886 | 0.76 | POLB (0.68) | CYP19A1TBXAS1POLBGAASOD1 | |
| SCHEMBL9849511 | 0.76 | TLR8 (0.57) | CYP19A1TBXAS1TSHRSOD1 | |
| SCHEMBL9849506 | 0.75 | KDM4E (0.39) | CYP19A1TBXAS1POLB | |
| SCHEMBL9849295 | 0.74 | TSHR (0.55) | CYP19A1TSHRGAAALDH1A1GSK3A | |
| SCHEMBL9849881 | 0.72 | GAA (0.55) | CYP19A1TBXAS1TSHRGAAALDH1A1 | |
| SCHEMBL9849597 | 0.71 | SOD1 (0.48) | CYP19A1POLBTSHRALDH1A1SOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0446604-A2 | Pyridine and related aza heterocycle derivatives as cardiovascular agents | AMERICAN CYANAMID COMPANY (US) | 1991-09-18 | — | — | EP | disclosed |